Mutations in ryanodine receptor 2 (RyR2), a Ca2+ release channel located in the sarcoplasmic reticulum (SR), or calsequestrin 2 (CASQ2), a SR Ca2+ binding protein, are linked to CPVT. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.